NMDA Receptor Antagonists

NMDA receptor antagonists play a crucial role in Alzheimer's disease and dementia by modulating glutamate activity in the brain. Glutamate, an excitatory neurotransmitter, is implicated in neurodegenerative processes when present in excess. NMDA receptor antagonists, such as memantine, work by blocking these receptors, thereby regulating glutamate levels and reducing neuronal damage associated with Alzheimer's disease progression. This class of drugs helps improve cognitive function and delay symptom progression by maintaining neurotransmitter balance. Unlike other treatments, NMDA receptor antagonists target specific mechanisms of neurodegeneration, offering a unique therapeutic approach in managing Alzheimer's disease and related dementias. Ongoing research continues to explore their efficacy and potential in providing symptomatic relief and possibly altering disease progression in affected individuals.